SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy)
Abstract
:1. Introduction
2. Materials and Methods
2.1. Setting and Study Population
2.2. Data Collection and Measurements
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Shereen, M.A.; Khan, S.; Kazmi, A.; Bashir, N.; Siddique, R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020, 16, 91–98. [Google Scholar] [CrossRef] [PubMed]
- Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020, 5, 536–544. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it (accessed on 14 November 2020).
- World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (accessed on 14 November 2020).
- Istituto Superiore di Sanità. Available online: https://www.iss.it/coronavirus (accessed on 14 November 2020).
- La Rosa, G.; Mancini, P.; Ferraro, G.B.; Veneri, C.; Iaconelli, M.; Bonadonna, L.; Lucentini, L.; Suffredini, E. SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring. Sci. Total Environ. 2020, 750, 141711. [Google Scholar] [CrossRef] [PubMed]
- Decreto del Presidente del Consiglio dei Ministri (DPCM) 11 Marzo 2020 (GU Serie Generale n.64 del 11/03/2020). Available online: https://www.gazzettaufficiale.it/eli/id/2020/03/11/20A01605/sg (accessed on 14 November 2020).
- Decreto del Presidente del Consiglio dei Ministri (DPCM) 26 Aprile 2020 (GU Serie Generale n.108 del 27/04/2020). Available online: https://www.gazzettaufficiale.it/eli/id/2020/04/27/20A02352/sg (accessed on 14 November 2020).
- Decreto del Presidente del Consiglio dei Ministri (DPCM) 17 Maggio 2020 (GU Serie Generale n.126 del 17/05/2020). Available online: https://www.gazzettaufficiale.it/eli/id/2020/05/17/20A02717/sg (accessed on 14 November 2020).
- Decreto del Presidente del Consiglio dei Ministri (DPCM) 11 Giugno 2020 (GU Serie Generale n.147 del 11/06/2020). Available online: https://www.gazzettaufficiale.it/eli/id/2020/06/11/20A03194/sg (accessed on 14 November 2020).
- Dipartimento della Protezione civile. Available online: http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1 (accessed on 14 November 2020).
- Sartor, G.; Del Riccio, M.; Dal Poz, I.; Bonanni, P.; Bonaccorsi, G. Covid-19 in Italy: Consideration on official data. Int. J. Infect. Dis. 2020, 98, 188–190. [Google Scholar] [CrossRef] [PubMed]
- Istituto Superiore di Sanità. Available online: https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-dashboard (accessed on 14 November 2020).
- Ministero della Salute. Protocollo metodologico per un’indagine di siero-prevalenza sul SARS-CoV-2 condotta dal Ministero della salute e dall’ISTAT. Available online: http://www.salute.gov.it/imgs/C_17_campagneComunicazione_146_0_file.pdf (accessed on 14 November 2020).
- Mansour, M.; Leven, E.; Muellers, K.; Stone, K.; Mendu, D.R.; Wajnberg, A. Prevalence of SARS-CoV-2 antibodies among healthcare workers at a tertiary academic hospital in New York City. J. Gen. Intern. Med. 2020, 35, 2485–2486. [Google Scholar] [CrossRef] [PubMed]
- Plebani, M.; Padoan, A.; Fedeli, U.; Schievano, E.; Vecchiato, E.; Lippi, G.; Lo Cascio, G.; Porru, S.; Palù, G. SARS-CoV-2 serosurvey in health care workers of the Veneto Region. Clin. Chem. Lab. Med. 2020, 58, 2107–2111. [Google Scholar] [CrossRef] [PubMed]
- Jespersen, S.; Mikkelsen, S.; Greve, T.; Kaspersen, K.A.; Tolstrup, M.; Boldsen, J.K.; Redder, J.D.; Nielsen, K.; Abildgaard, A.M.; Kolstad, H.A.; et al. SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region. Clin. Infect. Dis. 2020. [Google Scholar] [CrossRef] [PubMed]
- Iversen, K.; Bundgaard, H.; Hasselbalch, R.B.; Kristensen, J.H.; Nielsen, P.B.; Pries-Heje, M.; Knudsen, A.D.; Christensen, C.E.; Fogh, K.; Norsk, J.B.; et al. Risk of COVID-19 in health-care workers in Denmark: An observational cohort study. Lancet Infect. Dis. 2020, 20, 1401–1408. [Google Scholar] [CrossRef]
- Agenzia Regionale di Sanità Toscana. Available online: https://www.ars.toscana.it/images/qualita_cure/coronavirus/rapporti_Covid-19/report_covid19_17_luglio.pdf (accessed on 14 November 2020).
- Agenzia Regionale di Sanità Toscana. Available online: https://www.ars.toscana.it/banche-dati/dati-sintesi-sintcovid-aggiornamenti-e-novita-sul-numero-dei-casi-deceduti-tamponi-per-provincia-e-per-asl-della-regione-toscana-e-confronto-con-italia-con-quanti-sono-i-decessi-per-comune?provenienza=home_ricerca&dettaglio=ric_geo_covid&par_top_geografia=090 (accessed on 14 November 2020).
- Regione Toscana. Ordinanza della Presidente della Giunta Regionale n° 23 del 3 aprile 2020. Available online: http://www301.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5251885&nomeFile=Ordinanza_del_Presidente_n.23_del_03-04-2020 (accessed on 14 November 2020).
- Regione Toscana. Ordinanza della Presidente della Giunta Regionale n° 39 del 19 aprile 2020. Available online: http://www301.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5250090&nomeFile=Ordinanza_del_Presidente_n.39_del_19-04-2020 (accessed on 14 November 2020).
- Baldassar, L.; Johanson, G.; McAuliffe, N.; Bressan, M. Chinese Migration to Europe. Prato, Italy, and Beyond, 1st ed.; Palgrave Macmillan: London, UK, 2015; pp. 1–349. [Google Scholar] [CrossRef]
- Murhekar, M.V.; Bhatnagar, T.; Selvaraju, S.; Rade, K.; Saravanakumar, V.; Vivian Thangaraj, J.W.; Kumar, M.S.; Shah, N.; Sabarinathan, R.; Turuk, A.; et al. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May–June 2020. Indian J. Med. Res. 2020, 152, 48–60. [Google Scholar] [CrossRef] [PubMed]
- Pollán, M.; Pérez-Gómez, B.; Pastor-Barriuso, R.; Oteo, J.; Hernán, M.A.; Pérez-Olmeda, M.; Sanmartín, J.L.; Fernández-García, A.; Cruz, I.; de Larrea, N.F.; et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): A nationwide, population-based seroepidemiological study. Lancet 2020, 396, 535–544. [Google Scholar] [CrossRef]
- Istituto Nazionale di Statistica (ISTAT). Primi risultati dell’indagine di sieroprevalenza sul SARS-CoV-2. Available online: https://www.istat.it/it/files/2020/08/ReportPrimiRisultatiIndagineSiero.pdf (accessed on 14 November 2020).
- Steensels, D.; Oris, E.; Coninx, L.; Nuyens, D.; Delforge, M.L.; Vermeersch, P.; Heylen, L. Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium. JAMA 2020, 324, 195–197. [Google Scholar] [CrossRef] [PubMed]
- Moscola, J.; Sembajwe, G.; Jarrett, M.; Farber, B.; Chang, T.; McGinn, T.; Davidson, K.W. Northwell Health COVID-19 Research Consortium. Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area. JAMA 2020, 324, 893–895. [Google Scholar] [CrossRef] [PubMed]
- Korth, J.; Wilde, B.; Dolff, S.; Anastasiou, O.E.; Krawczyk, A.; Jahn, M.; Cordes, S.; Ross, B.; Esser, S.; Lindemann, M.; et al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J. Clin. Virol. 2020, 128, 104437. [Google Scholar] [CrossRef] [PubMed]
- Sandri, M.T.; Azzolini, E.; Torri, V.; Carloni, S.; Tedeschi, M.; Castoldi, M.; Mantovani, A.; Rescigno, M. IgG serology in health care and administrative staff populations from 7 hospital representative of different exposures to SARS-CoV-2 in Lombardy, Italy. medRxiv 2020. [Google Scholar] [CrossRef]
- Self, W.H.; Tenforde, M.W.; Stubblefield, W.B.; Feldstein, L.R.; Steingrub, J.S.; Shapiro, N.I.; Ginde, A.A.; Prekker, M.E.; Brown, S.M.; Peltan, I.D.; et al. CDC COVID-19 Response Team; IVY Network. Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network—13 academic medical centers, April–June 2020. MMWR Morb. Mortal Wkly. Rep. 2020, 69, 1221–1226. [Google Scholar] [CrossRef] [PubMed]
- ARS Toscana. Regione Toscana. Rapporto sui casi di Infezione da SARS-CoV-2 in Toscana. Rapporto 25 Settembre 2020. Available online: https://www.ars.toscana.it/images/qualita_cure/coronavirus/rapporti_Covid-19/Rapporto_COVID-19_25_SETTEMBRE_2020_DEF.pdf (accessed on 14 November 2020).
- Shields, A.; Faustini, S.E.; Perez-Toledo, M.; Jossi, S.; Aldera, E.; Allen, J.D.; Al-Taei, S.; Backhouse, C.; Bosworth, A.; Dunbar, L.A.; et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: A cross-sectional study. Thorax 2020, 75, 1089–1094. [Google Scholar] [CrossRef] [PubMed]
- U.S. Food and Drug Administration (FDA). EUA Authorized Serology Test Performance. Available online: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/eua-authorized-serology-test-performance (accessed on 3 December 2020).
Type of Service | N (% of the whole sample) | N of Males (% within the Group) * | Median Age, Years (IQR) # | N of Positive Participants (% of within the Group) * | % Positive Participants 95% CI |
---|---|---|---|---|---|
Work-from-home | 725 (15.6%) | 248 (34.2%) | 49.0 (39.7–56.0) | 7 (1.0%) | 0.3%–2.0% |
Support Service (total) | 1103 (23.7%) | 481 (43.6%) | 50.0 (36.0–61.0) | 15 (1.4%) | 0.7%–2.2% |
Community support service | 502 (10.8%) | 327 (65.1%) | 53.3 (34.3–64.5) | 5 (1.0%) | 0.3%–2.3% |
Local health authority support service | 601 (12.9%) | 154 (25.6%) | 48.0 (37–59.0) | 10 (1.7%) | 0.8–3.0% |
Health Service | 2828 (60.7%) | 803 (28.4%) | 48.0 (38.0–56.0) | 116 (4.1%) | 3.4%–4.9% |
Total sample | 4656 (100%) | 1532 (32.9%) | 49.0 (38.0–57.0) | 138 (3.0%) | 2.5%–3.5% |
Variables | OR | 95% Confidence Intervals | p |
---|---|---|---|
Age 1 | 1.00 | 0.99–1.02 | 0.84 |
Sex | |||
Male (Ref.) | 1 | - | - |
Female | 1.01 | 0.70–1.48 | 0.97 |
Type of service | |||
Work-from-home (Ref.) | 1 | - | - |
Community support service | 1.03 | 0.30–3.26 | 0.96 |
Local health authority support service | 1.73 | 0.66–4.80 | 0.27 |
Health service | 4.39 | 2.19–10.43 | <0.01 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lastrucci, V.; Lorini, C.; Del Riccio, M.; Gori, E.; Chiesi, F.; Sartor, G.; Zanella, B.; Boccalini, S.; Bechini, A.; Puggelli, F.; et al. SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy). Vaccines 2020, 8, 778. https://doi.org/10.3390/vaccines8040778
Lastrucci V, Lorini C, Del Riccio M, Gori E, Chiesi F, Sartor G, Zanella B, Boccalini S, Bechini A, Puggelli F, et al. SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy). Vaccines. 2020; 8(4):778. https://doi.org/10.3390/vaccines8040778
Chicago/Turabian StyleLastrucci, Vieri, Chiara Lorini, Marco Del Riccio, Eleonora Gori, Fabrizio Chiesi, Gino Sartor, Beatrice Zanella, Sara Boccalini, Angela Bechini, Francesco Puggelli, and et al. 2020. "SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy)" Vaccines 8, no. 4: 778. https://doi.org/10.3390/vaccines8040778
APA StyleLastrucci, V., Lorini, C., Del Riccio, M., Gori, E., Chiesi, F., Sartor, G., Zanella, B., Boccalini, S., Bechini, A., Puggelli, F., Bonanni, P., & Bonaccorsi, G. (2020). SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy). Vaccines, 8(4), 778. https://doi.org/10.3390/vaccines8040778